Incyte
INCY
#984
Rank
NZ$42.86 B
Marketcap
NZ$210.32
Share price
-1.64%
Change (1 day)
16.54%
Change (1 year)

P/S ratio for Incyte (INCY)

P/S ratio as of November 2026 (TTM): 3.93

According to Incyte's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 4.19. At the end of 2026 the company had a P/S ratio of 3.89.

P/S ratio history for Incyte from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20263.890.4%
20253.8723.16%
20243.14-17.41%
20233.81-27.67%
20225.26-3.05%
20215.43-23.99%
20207.14-18.31%
20198.7421.33%
20187.21-44.61%
201713.0-23.84%
201617.1-36.39%
201526.99.95%
201424.45.06%
201323.2211.53%
20127.46-62.82%
201120.167.01%
201012.0-89.72%
200911724.43%
200893.9280.86%
200724.739.05%
200617.7-68.82%
200556.9-26.13%
200477.0630.92%
200310.5249.52%
20023.01-49.06%
20015.92

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Novartis
NVS
4.98 26.71%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.47-37.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
13.9 254.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
6.10 55.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
22.6 475.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Geron
GERN
2.70-31.18%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
15.8 302.66%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
5.53 40.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
1.64-58.19%๐Ÿ‡บ๐Ÿ‡ธ USA